IRIS
MAGGI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.659
AS - Asia 1.909
EU - Europa 739
Continente sconosciuto - Info sul continente non disponibili 449
SA - Sud America 257
AF - Africa 87
OC - Oceania 7
Totale 6.107
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.466
SG - Singapore 493
CN - Cina 457
IT - Italia 394
BD - Bangladesh 329
VN - Vietnam 213
BR - Brasile 149
HK - Hong Kong 106
FR - Francia 67
CA - Canada 65
DE - Germania 58
IN - India 53
AR - Argentina 42
GB - Regno Unito 40
MX - Messico 37
ID - Indonesia 33
TR - Turchia 33
RU - Federazione Russa 32
PK - Pakistan 27
IQ - Iraq 26
SE - Svezia 24
CR - Costa Rica 22
ZA - Sudafrica 22
ES - Italia 21
JM - Giamaica 21
PH - Filippine 21
SA - Arabia Saudita 20
MY - Malesia 19
PL - Polonia 19
VE - Venezuela 17
FI - Finlandia 16
NL - Olanda 16
IL - Israele 15
EC - Ecuador 14
SC - Seychelles 13
UA - Ucraina 12
AE - Emirati Arabi Uniti 11
CL - Cile 10
GT - Guatemala 10
DZ - Algeria 9
HN - Honduras 9
JP - Giappone 9
MA - Marocco 9
CO - Colombia 7
AU - Australia 6
PR - Porto Rico 6
UY - Uruguay 6
EG - Egitto 5
IE - Irlanda 5
JO - Giordania 5
PY - Paraguay 5
TN - Tunisia 5
AL - Albania 4
KR - Corea 4
NI - Nicaragua 4
PE - Perù 4
RO - Romania 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BB - Barbados 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
HU - Ungheria 3
KE - Kenya 3
KZ - Kazakistan 3
LU - Lussemburgo 3
LY - Libia 3
NP - Nepal 3
PS - Palestinian Territory 3
SN - Senegal 3
TH - Thailandia 3
TW - Taiwan 3
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
BZ - Belize 2
CG - Congo 2
KH - Cambogia 2
LB - Libano 2
MR - Mauritania 2
MV - Maldive 2
PT - Portogallo 2
QA - Qatar 2
AG - Antigua e Barbuda 1
AI - Anguilla 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
BM - Bermuda 1
BS - Bahamas 1
CD - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
Totale 5.638
Salva come PNG Salva come JPEG
Città #
San Jose 384
New York 182
Singapore 149
Phoenix 146
Council Bluffs 112
Hong Kong 103
Ashburn 100
Beijing 75
Santa Clara 71
Ho Chi Minh City 63
Hanoi 51
Rome 40
Milan 30
Los Angeles 29
Hillsboro 25
Buffalo 24
Naples 24
Dallas 18
Bemidji 17
San José 16
Warsaw 16
Bologna 14
Da Nang 14
São Paulo 14
Helsinki 13
Philadelphia 13
Houston 12
Kingston 12
Toronto 12
Atlanta 11
Birmingham 11
Haiphong 11
Istanbul 11
Montreal 11
Newark 11
Nuremberg 11
Reston 11
Rockville 11
Baghdad 10
Boise 10
Chicago 10
Johannesburg 10
Seattle 10
Catania 9
Kuala Lumpur 9
Lancaster 9
Mexico City 9
San Francisco 9
Frankfurt am Main 8
Palermo 8
Friday Harbor 7
Guatemala City 7
Jakarta 7
Las Vegas 7
Miami 7
Princeton 7
San Jacinto 7
Caracas 6
Florence 6
Jeddah 6
Karachi 6
Lahore 6
Limburg an der Lahn 6
North Hollywood 6
Orem 6
Quito 6
Stony Brook 6
Turin 6
Belo Horizonte 5
Bend 5
Brooklyn 5
Cairo 5
Cape Town 5
Charlotte 5
Detroit 5
Genoa 5
Janesville 5
Pasadena 5
San Pedro Sula 5
The Bronx 5
Tokyo 5
Algiers 4
Amman 4
Anderson 4
Brasília 4
Brescia 4
Campinas 4
Cincinnati 4
Dammam 4
Go Vap 4
Hai Bà Trưng 4
Lanús 4
Managua 4
Montevideo 4
Nottingham 4
Petaling Jaya 4
Pune 4
Quận Ba 4
Raleigh 4
Reggio Emilia 4
Totale 2.245
Salva come PNG Salva come JPEG
Nome #
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 117
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 96
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 94
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 39
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 37
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 33
Prevalence and Epidemiological and Clinical Features of Bacterial Infections in a Large Cohort of Patients Hospitalized for COVID-19 in Southern Italy: A Multicenter Study 33
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 33
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 33
Adipocyte differentiation of 3T3-L1 cells under TAF, TDF and INSTIs selective challenge: an in vitro model 32
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort 32
Utilizzo della definizione di Sindrome metabolica e del Framingham risk score per identificare pazienti naive a maggior rischio cardiovascolare. Risultato dello studio multicentrico HERMES 30
A color-doppler ultrasonographic comparative study between patients treated with PI-including regimens vs NNRTI-including regimens (Prevaleat study) 28
In vitro modulation of adipocyte differentiation by tenofovir alafenamide/disoproxil fumarate following challenge with recent ARV drugs 28
Lipids and Body Mass Index in Antiretroviral‐Experienced People With HIV on Doravirine‐Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir‐Based Triple Regimen 27
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 27
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study 27
Smoking Cessation in People Living With HIV: Results From Italian STOPSHIV Project Cohort 27
Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort 27
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 26
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 25
The Role of Immune Dysregulation Markers in Cardiovascular Risk of People Living with HIV: Association Among Intima Media Changes, CD4/CD8 Ratio, and CD4+ Cell Count Nadir 25
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 25
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 24
Genomic Characterization of the Emerging SARS-CoV-2 Lineage in Two Districts of Campania (Italy) Using Next-Generation Sequencing 24
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study 24
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics) 24
. Long term non progressors among IVDA: behavioural, clinical and virological aspects 23
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial 23
Epidemiological, clinical and therapeutic evaluation of the italian cholera epidemic in 1994 23
Leishmaniosi viscerale in Puglia: indagine policentrica conoscitiva 22
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 22
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient 22
Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions 22
Intestinal microsporidiosis in AIDS patients with diarrhoeal illness in Apulia (South Italy) 21
. Cutaneous reactions in HIV-1 positive patients treated with enfuvirtide 21
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 21
La gestione del rischio cardiovascolare nel paziente HIV-positivo 21
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 21
Ulteriore espansione dell'epidemia di HCV in pazienti emodializzati: valutazione clinico-epidemiologica alla luce dei tests diagnostici di II generazione 21
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy 21
RADAR Study Group of the Master Cohort. Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patients 20
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 20
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 20
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 20
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 19
Factors associated with hospital admission for COVID-19 in HIV patients 19
Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors 19
Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project 19
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 19
A nodular pulmonary lesion due to Linguatula serrata in an HV-positive man 19
Ripetitive surgery for mycotic aneurysm due to Pseudomonas aeruginosa: clinical and bacteriological aspects 19
Distance from low-density lipoprotein cholesterol targets across cardiovascular risk strata in people living with HIV: A multicentre cohort study 19
Accettabilità del condom: studio su una coorte di tossicodipendenti e loro partners 19
Cardiovascular risk in advanced naive HIV-infected atients starting antiretroviral therapy: comparison of three different regimens based on ATV, DRV or EFV – PREVALEAT II (Premature Vascular Lesions and Antiretroviral Therapy II) Cohort 19
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 19
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 18
Implications of AB0 blood group in hypertensive patients with covid-19 18
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV-specific risk factors; the Archi-Prevaleat project 18
Effects of therapy with maraviroc on the carotid intima media thickness in HIV-1/HCV Co-infected patients 18
Antiretroviral therapy and hyperhomocysteinemia: a possibile risk for cardiovascular disease in HIV-1 positive patients 18
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study 18
Su due casi di Leishmania-HIV osservati in Puglia 18
A greater prevalence of X4 viruses in HIV type 1 intravenous drug users reflects a "CD4+ effect" 18
National multicentric study on maintenance therapy for CMV disease in AIDS patients 18
A Cyanobacterium-Like Body found in the stools of an HIV+ patient with diarrhoea 18
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 18
Cyclospora-like bodies in AIDS patients 18
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 18
Reazioni nel sito di iniezione in pazienti trattati a lungo termine con enfuvirtide 18
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile 18
A case of human brucellosis caused by accidental injection of animal vaccine 18
Tossicità a lungo termine delle terapie antiretrovirali 18
Epatite NANB in pazienti emodializzati: formulazione di un protocollo diagnostico 18
Long-term administration of Inosine-Pranobex (INPX) in anti-HIV asymptomatic carriers. Preliminary results of a controlled study 18
Behavioural, clinical and virological aspects in a cohort of Long Term non Progressors 18
B-mode Ultrasound Study of Carotid Plaques in HIV-positive Patients to Detect the Presence of Inflammatory Endothelial Lesions 18
Evaluation of antiretroviral therapy in patients with at least one year of treatment 17
et al. Atherosclerosis, vascular events and dementia risk in HIV-infected patients. Preliminary data from the Italian multicentre cohort of the Cardiovascular and late-life dementia risk in HIV (CARDH) Study 17
Modificazioni dell'intima-media carotidea, attivazione endoteliale e marker di infiammazione in pazienti HIV-positivi naive avanzati che iniziano terapia antiretrovirale: studio PREVALEAT II. Rapporto in itinere 17
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 17
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 17
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 17
Haart and cardiovascular toxicity: a chapter to rewrite? 17
Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV 17
. First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006) 17
La percezione della malattia renale nelle persone con infezione da HIV: un approccio di medicina narrativa 17
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 16
I Centri-dialisi: un modello epidemiologico di diffusione del virus epatitico C 16
Prevalence of hypertension in HIV infected patients: results from the HIVY Study 16
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 16
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 16
Pazienti HIV positivi in trattamento con HAART: Efficacia in soggetti con persistente viremia 16
Nontyphoidal salmonellosis in AIDS: epidemiological and clinical features in South-Eastern Italy 16
Role of chlamydia infection in the pathogenesis of atherosclerotic plaques in HIV-1-positive patients 16
Insufficienza renale acuta da rabdomiolisi (caso clinico) 16
A retrospective study on non transfusional HCV hepatitis in hemodialized patients 16
Infezioni da anaerobi 16
Assessment of biological risk of blood transmission among health workers at a Bari university hospital 16
The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection 16
Totale 2.346
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/20264.611 0 0 0 0 22 19 1 2.063 1.039 732 388 347
2026/20271.496 147 271 358 720 0 0 0 0 0 0 0 0
Totale 6.107